Machine learning-driven prioritization of lipoprotein(a) testing: model development and validation

European Journal of Preventive Cardiology 2026 Open access

Read full text
Authors: Christophe A. T. Stevens, Fotios Barkas, Julia Brandts, Sunganani Kwilasi, Kanika Dharmayat, Amany Elshorbagy, Irene Karungi, Alireza S. Mahani, Mansour T A Sharabiani, Dr Antonio J. Vallejo-Vaz, Kausik K Ray
DOI: 10.1093/eurjpc/zwag185
Cited by: 1
References: 21

Abstract

AIMS: Elevated lipoprotein(a) [Lp(a)] is a common risk factor for cardiovascular disease (CVD) affecting ∼1.4 billion people globally, with novel treatments under development. Guidelines recommend one-lifetime measurement, yet

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Atherosclerosis and Cardiovascular Diseases Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
European Journal of Preventive Cardiology
Publisher
Oxford University Press (OUP)
Publication date
27 March 2026
Language
EN